CTOs on the Move

Amgen

www.amgen.com

 
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology. Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people`s lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world`s leading independent biotechnology companies, has reached millions of patients around the world and is ...
  • Number of Employees: 5K-10K
  • Annual Revenue: > $1 Billion
  • www.amgen.com
  • One Amgen Center Drive
    Thousand Oaks, CA USA 91320
  • Phone: 805.447.1000

Executives

Name Title Contact Details
Darren Lensky
 Director, Information Security - Digital Governance, Risk & Compliance Profile
Naresh Vurukonda
 Associate Director, Information Systems Profile
Scott Skellenger
 Senior Vice President and Chief Information Officer Profile
Patrick Zeller
 Chief Privacy Officer and Sr. Cybersecurity Profile
David Reese
 Executive Vice President and Chief Technology Officer Profile

Similar Companies

Tropical Looks Day Spa

Tropical Looks Day Spa is a Vacaville, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Adarza BioSystems Inc

Adarza BioSystems, Inc. manufactures a label-free platform technology that enables the simultaneous detection of hundreds of analytes in a single drop of fluid.

GeneGo bioinformatics software

GeneGo bioinformatics software is a Saint Joseph, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Access Bio Inc

Access Bio Inc is a Somerset, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

KalVista Pharmaceuticals

KalVista is a clinical stage pharmaceuticals company focused on the discovery, development, and commercialization of small molecule protease inhibitors.